Surgical Strategies for Adenocarcinoma of the Esophagogastric Junction

  • Marc Schiesser
  • Paul M. SchneiderEmail author
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 182)


This chapter summarizes the surgical strategies for adenocarcinomas of the distal esophagus, gastric cardia, and subcardial gastric cancer invading the cardia ± distal esophagus known as adenocarcinomas of the esophagogastric junction (AEG). The different surgical approaches according to the tumor origin, localization, and tumor stage are addressed with particular attention to the extent and type of resection and appropriate lymphadenectomy (LAD). The classification of AEG according to Siewert is helpful for the selection of the surgical strategy. While type I tumors benefit from a transthoracic en bloc esophagectomy including a two-field LAD, type II and III tumors can be treated by an extended total gastrectomy with a transhiatal resection of the distal esophagus and LAD of the lower mediastinum and the abdominal D2 compartment. Limited resections appear to be ­possible for early tumor stages in selected cases of type I–III tumors.


Endoscopic Mucosal Resection Distal Esophagus Limited Resection Laparoscopic Total Gastrectomy Jejunal Interposition 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Aikou T, Shimazu H (1989) Difference in main lymphatic pathways from the lower esophagus and gastric cardia. Jpn J Surg 19(3):290–295PubMedCrossRefGoogle Scholar
  2. Aikou T, Higashi H, Natsugoe S et al (2001) Can sentinel node navigation surgery reduce the extent of lymph node dissection in gastric cancer? Ann Surg Oncol 8(9 suppl):90S–93SPubMedGoogle Scholar
  3. Altorki N, Kent M, Ferrara C et al (2002) Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236(2):177–183PubMedCrossRefGoogle Scholar
  4. Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85(6):840–844PubMedCrossRefGoogle Scholar
  5. Bizekis C, Kent MS, Luketich JD et al (2006) Initial experience with minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg 82(2):402–406; discussion 406–407Google Scholar
  6. Bo T, Zhihong P, Peiwu Y et al (2009) General complications following laparoscopic-assisted gastrectomy and analysis of techniques to manage them. Surg Endosc 23:1860–1865Google Scholar
  7. Bollschweiler E, Baldus SE, Schroder W et al (2006) High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 38(2):149–156PubMedCrossRefGoogle Scholar
  8. Bonenkamp JJ, Hermans J, Sasako M et al (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340(12):908–914PubMedCrossRefGoogle Scholar
  9. Burian M, Stein HJ, Sendler A et al (2004) Sentinel node detection in Barrett’s and cardia cancer. Ann Surg Oncol 11(3 Suppl):255S–258SPubMedGoogle Scholar
  10. Cense HA, Visser MR, van Sandick JW et al (2004) Quality of life after colon interposition by necessity for esophageal cancer replacement. J Surg Oncol 88(1):32–38PubMedCrossRefGoogle Scholar
  11. D’Journo XB, Doddoli C, Michelet P et al (2005) Transthoracic esophagectomy for adenocarcinoma of the oesophagus: standard versus extended two-field mediastinal lymphadenectomy? Eur J Cardiothorac Surg 27(4):697–704PubMedCrossRefGoogle Scholar
  12. D’Journo XB, Ferraro P, Martin J et al (2009) Barrett’s esophagus in the esophageal remnant: a critical long-term complication of subtotal esophagectomy. Ann Surg Oncol 16(5):1429; author reply 1430–1431Google Scholar
  13. Dresner SM, Griffin SM (2000) Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg 87(10):1426–1433PubMedCrossRefGoogle Scholar
  14. Ell C, May A, Gossner L et al (2000) Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology 118(4):670–677PubMedCrossRefGoogle Scholar
  15. Feith M, Stein HJ, Siewert JR (2006) Adenocar­cinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am 15(4):751–764PubMedCrossRefGoogle Scholar
  16. Gall FP, Hermanek P (1985) New aspects in the surgical treatment of gastric carcinoma–a comparative study of 1636 patients operated on between 1969 and 1982. Eur J Surg Oncol 11(3):219–225PubMedGoogle Scholar
  17. Griffith JP, Sue-Ling HM, Martin I et al (1995) Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut 36(5):684–690PubMedCrossRefGoogle Scholar
  18. Hofstetter W, Correa AM, Bekele N et al (2007) Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 84(2):365–373; discussion 374–375Google Scholar
  19. Holscher AH, Bollschweiler E, Schneider PM et al (1997) Early adenocarcinoma in Barrett’s oeso­phagus. Br J Surg 84(10):1470–1473PubMedCrossRefGoogle Scholar
  20. Holscher AH, Schroder W, Bollschweiler E et al (2003) [How safe is high intrathoracic esophagogastrostomy?]. Chirurg 74(8):726–733Google Scholar
  21. Holscher AH, Schneider PM, Gutschow C et al (2007) Laparoscopic ischemic conditioning of the stomach for esophageal replacement. Ann Surg 245(2):241–246PubMedCrossRefGoogle Scholar
  22. Hulscher JB, van Sandick JW, Tijssen JG et al (2000) The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg 191(2):143–148PubMedCrossRefGoogle Scholar
  23. Hulscher JB, van Sandick JW, de Boer AG et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347(21):1662–1669PubMedCrossRefGoogle Scholar
  24. Katai H, Sano T, Fukagawa T et al (2003) Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach. Br J Surg 90(7):850–853PubMedCrossRefGoogle Scholar
  25. Kitagawa Y, Kitano S, Kubota T et al (2005a) Minimally invasive surgery for gastric cancer–toward a confluence of two major streams: a review. Gastric Cancer 8(2):103–110PubMedCrossRefGoogle Scholar
  26. Kitagawa Y, Fujii H, Mukai M et al (2005b) Sentinel lymph node mapping in esophageal and gastric cancer. Cancer Treat Res 127:123–139PubMedCrossRefGoogle Scholar
  27. Kitajima M, Kitagawa Y, Fujii H et al (2005) Credentialing of nuclear medicine physicians, surgeons, and pathologists as a multidisciplinary team for selective sentinel lymphadenectomy. Cancer Treat Res 127:253–267PubMedCrossRefGoogle Scholar
  28. Kulig J, Popiela T, Kolodziejczyk P et al (2007) Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 193(1):10–15PubMedCrossRefGoogle Scholar
  29. Lauren PA, Nevalainen TJ (1993) Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas. Cancer 71(10):2926–2933PubMedCrossRefGoogle Scholar
  30. Lerut T, Nafteux P, Moons J et al (2004) Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240(6):962–972; discussion 972–974Google Scholar
  31. Maruyama K, Gunven P, Okabayashi K et al (1989) Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 210(5):596–602PubMedCrossRefGoogle Scholar
  32. Merendino KA, Dillard DH (1955) The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiologic abnormalities at the esophagogastric junction; with special reference to reflux esophagitis, cardiospasm and esophageal varices. Ann Surg 142(3):486–506PubMedCrossRefGoogle Scholar
  33. Motoyama S, Saito R, Okuyama M et al (2006) Treating gastric tube cancer with distal gastrectomy preserving the gastroepiploic artery. Ann Thorac Surg 81(2):751–753PubMedCrossRefGoogle Scholar
  34. Nakajima M, Kato H, Miyazaki T et al (2007) Comprehensive investigations of quality of life after esophagectomy with special reference to the route of reconstruction. Hepatogastroenterology 54(73):104–110PubMedGoogle Scholar
  35. Nguyen NT, Hinojosa MW, Smith BR et al (2008) Minimally invasive esophagectomy: lessons learned from 104 operations. Ann Surg 248(6):1081–1091PubMedCrossRefGoogle Scholar
  36. Nishihira T, Hirayama K, Mori S (1998) A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 175(1):47–51PubMedCrossRefGoogle Scholar
  37. Omloo JM, Lagarde SM, Hulscher JB et al (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246(6):992–1000; discussion 1000–1001Google Scholar
  38. Ozawa S, Ando N, Kitagawa Y et al (1998) [Does incidence of carcinoma of the esophagogastric junction increase?]. Nippon Geka Gakkai Zasshi 99(9):542–546Google Scholar
  39. Pech O, Ell C (2009) Endoscopic therapy of Barrett’s esophagus. Curr Opin Gastroenterol 25:405–411Google Scholar
  40. Pera M, Manterola C, Vidal O et al (2005) Epidemiology of esophageal adenocarcinoma. J Surg Oncol 92(3):151–159PubMedCrossRefGoogle Scholar
  41. Peyre CG, Hagen JA, DeMeester SR et al (2008a) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248(4):549–556PubMedGoogle Scholar
  42. Peyre CG, Hagen JA, DeMeester SR et al (2008b) Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 248(6):979–985PubMedCrossRefGoogle Scholar
  43. Portale G, Hagen JA, Peters JH et al (2006) Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg 202(4):588–596; discussion 596–598Google Scholar
  44. Sasako M, Sano T, Yamamoto S et al (2006) Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 7(8):644–651PubMedCrossRefGoogle Scholar
  45. Sauvanet A, Mariette C, Thomas P et al (2005) Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors. J Am Coll Surg 201(2):253–262PubMedCrossRefGoogle Scholar
  46. Scheepers JJ, van der Peet DL, Veenhof AA et al (2009) Systematic approach of postoperative gastric conduit complications after esophageal resection. Dis Esophagus 2009.Google Scholar
  47. Schroder W, Monig SP, Baldus SE et al (2002) Frequency of nodal metastases to the upper mediastinum in Barrett’s cancer. Ann Surg Oncol 9(8):807–811PubMedGoogle Scholar
  48. Schuchert MJ, Luketich JD, Landreneau RJ et al (2008) Minimally-invasive esophagomyotomy in 200 consecutive patients: factors influencing postoperative outcomes. Ann Thorac Surg 85(5):1729–1734PubMedCrossRefGoogle Scholar
  49. Schuhmacher C, Novotny A, Ott K et al (2007) [Lymphadenectomy with tumors of the upper gastrointestinal tract]. Chirurg 78(3):203–206, 208–212, 214–216Google Scholar
  50. Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85(11):1457–1459PubMedCrossRefGoogle Scholar
  51. Siewert JR, Holscher AH, Becker K et al (1987) [Cardia cancer: attempt at a therapeutically relevant classification]. Chirurg 58(1):25–32PubMedGoogle Scholar
  52. Siewert J, Feith M, Werner M et al (2000) Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on ­anatomical/topographic classification in 1002 consecutive patients. Ann Surg 232(3):9Google Scholar
  53. Siewert JR, Stein HJ, Feith M et al (2001) Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001 234(3):360–367; discussion 368–369Google Scholar
  54. Stein HJ, Feith M, Mueller J et al (2000) Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg 232(6):733–742PubMedCrossRefGoogle Scholar
  55. Stein HJ, Bartels H, Siewert JR (2001) Esophageal carcinoma: 2-stage operation for preventing mediastinitis in high risk patients. Chirurg 72(8):881–886PubMedCrossRefGoogle Scholar
  56. Tachimori Y, Kanamori N, Uemura N et al (2009) Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 137(1):49–54PubMedCrossRefGoogle Scholar
  57. Yuasa N, Miyake H, Yamada T et al (2006) Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction. World J Surg 30(3):364–371PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  1. 1.Department of SurgeryUniversity Hospital ZurichZurichSwitzerland

Personalised recommendations